Pharmacological effects of Chinese herbal active compounds in the intervention of polycystic ovary syndrome: focusing on molecular mechanisms
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by disturbances in glucose and lipid metabolism among women of reproductive age. In recent years, the active components of traditional Chinese medicine (TCM) have demonstrated significant potential in treating PCOS because of their unique pharmacological effects and fewer adverse reactions. Using keywords such as ‘polycystic ovary syndrome,’ ‘traditional Chinese medicine,’ and ‘blood-activating components,’ relevant content was searched across Chinese and English databases, including ‘CNKI, PubMed, VIP, and Web of Science.’ Published research papers on in vivo, in vitro, and clinical studies investigating the therapeutic effects of active ingredients in traditional Chinese medicine on PCOS were included as part of the selection criteria. TCM often utilizes compounds such as flavonoids, alkaloids, polyphenols, polysaccharides, saponins, and terpenoids as active ingredients. These components exert therapeutic effects on PCOS by alleviating inflammatory responses, modulating the structure of the gut microbiota and so on. The multitarget and holistic regulatory advantages of TCM offer promising prospects and significant implications for the treatment of PCOS. It can serve as an important complementary and alternative therapy, working synergistically with Western medicine to provide PCOS patients with more comprehensive, personalized, and fundamental treatment options.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.